Lophius Biosciences GmbH

https://www.lophius.com

Lophius Biosciences’ mission is to transform treatment paradigms and patient management with novel molecular diagnostic solutions for life-threatening and highly contagious infectious diseases. The core program addresses an unmet clinical need in tuberculosis (TB), a global epidemic affecting hundreds of millions of people. Lophius has developed a proprietary blood-based multi-marker solution, run on widely available platforms, to deliver a significant improvement in TB infection detection over existing approaches. Lophius is advancing biomarker combinations that would disrupt the field by being able to differentiate between active TB disease and latent TB infection. In addition, the company is commercializing a clinically validated CE-marked diagnostic kit (T-Track® CMV) that enables an improved and individualized risk stratification of CMV disease in transplant patients. *

	Start	2002-01-01 established
	Group	Mikrogen GmbH
	Predecessor	University Hospital Regensburg
	Industry	diagnostics (medical/biological)
	Industry 2	anti-infective drug
	Person	Wagner, Ralf (Lophius 201301– Managing Director before Geneart AG 1999– founder + CEO + CSO)
	Person 2	Lutz, Michael (HepaRegenix 201910– Managing Director (CEO) before LifeCodexx + Clinical Data/Cogenics + Epidauros)

	Region	Regensburg
	Country	Germany
	Street	13 Am BioPark
	City	93053 Regensburg
	Tel	+49-941-6309-197-0
		Address record changed: 2021-03-11

Basic data	Employees	B: 11 to 50 (2017-09-07)

		* Document for »About Section«: Mikrogen GmbH. (3/8/21). "Press Release: Mikrogen Acquires Lophius Biosciences to Expand into T Cell-Based Testing Market". Neuried & Regensburg.

		Record changed: 2023-12-30

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Mikrogen GmbH

[1] Mikrogen GmbH. (3/8/21). "Press Release: Mikrogen Acquires Lophius Biosciences to Expand into T Cell-Based Testing Market". Neuried & Regensburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)